Falu Lasarett

Futó vizsgálatok

• Toboroz

  A multicenter, randomized, open-label, blinded-assessor, phase 4 study in patients with early rheumatoid arthritis to compare active conventional therapy versus three biologic treatments, and two de-escalation strategies in patients who respond to treatment.

  NCT01491815· 4. fázis· Forrás

• Fut, nem toboroz

  Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

  NCT07037433· 3. fázis· Forrás

• Toboroz

  Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

  NCT07037459· 3. fázis· Forrás

• Toboroz

  PI4 - A Trial Assessing Metformin to Prolong Gestation in Preterm Preeclampsia

  NCT06033131· 3. fázis· Forrás

• Toboroz

  Immediate Curative vs Conservative Treatment in Older Men With M0, High-risk Prostate Cancer

  NCT05448547· 3. fázis· Forrás

• Toboroz

  A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments

  NCT05020236· 3. fázis· Forrás

• Fut, nem toboroz

  Effects of Bilberry and Oat Intake After Type 2 Diabetes and/or MI

  NCT03620266· Forrás

• Toboroz

  A Pilot Study on Intermittent Ibrutinib in Patients With Advanced-phase Chronic Lymphocytic Leukemia (CLL)

  NCT04771507· 1/2. fázis· Forrás

• Toboroz

  A Randomized Trial to Assess the Role of Imaging During Follow Up After Radical Surgery of High Risk Melanoma

  NCT03116412· Forrás

• Toboroz

  Surgery Versus Radiotherapy for Locally Advanced Prostate Cancer

  NCT02102477· Forrás

• Fut, nem toboroz

  Rectal Cancer And Pre-operative Induction Therapy Followed by Dedicated Operation. The RAPIDO Trial

  NCT01558921· 3. fázis· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Prosztatarák2 toboroz
• Elhízás1 toboroz
• Krónikus limfoid leukémia (CLL)1 toboroz
• Melanóma1 toboroz
• Rheumatoid arthritis1 toboroz
• Szívelégtelenség1 toboroz

Kutatók

Ide még nem kötődik kutató.

Lezárt vizsgálatok

• Lezárult

  Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke

  NCT03872401· 3. fázis· Forrás

• Lezárult

  A Study of Subcutaneous Daratumumab Versus Active Monitoring in Participants With High-Risk Smoldering Multiple Myeloma

  NCT03301220· 3. fázis· Forrás

• Lezárult

  A Study of Subcutaneous Versus (vs.) Intravenous Administration of Daratumumab in Participants With Relapsed or Refractory Multiple Myeloma

  NCT03277105· 3. fázis· Forrás

• Lezárult

  Standard Chemoimmunotherapy (FCR/BR) Versus Rituximab + Venetoclax (RVe) Versus Obinutuzumab (GA101) + Venetoclax (GVe) Versus Obinutuzumab + Ibrutinib + Venetoclax (GIVe) in Fit Patients With Previously Untreated Chronic Lymphocytic Leukemia (CLL) Without Del(17p) or TP53 Mutation

  NCT02950051· 3. fázis· Forrás